Navigation Links
The 4th Annual BIO Investor Forum to Webcast Alexza's Corporate Presentation
Date:10/3/2007

PALO ALTO, Calif., Oct. 3 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that its corporate presentation will be webcast live during the 4th Annual BIO Investor Forum on Thursday, October 11, 2007 at 4:30 p.m. Eastern Time. The presentation will be webcast from The Palace Hotel, San Francisco and may be accessed under the Investor Relations tab at http://www.alexza.com or http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=ALXA&item_id=16576 53. The presentation will be archived for 14 days.

Alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato(R) system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. The Company has six product candidates in development; AZ-004 (Staccato loxapine) for the treatment of acute agitation in schizophrenic and bipolar disorder patients, AZ-001 (Staccato prochlorperazine) for the acute treatment of migraine headaches, AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder, AZ-104 (Staccato loxapine) for the acute treatment of migraine headaches, AZ-003 (Staccato fenta
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. NameProtect releases annual list of top trademarkers
2. Doyle says new contracts saving state more than $16 million annually
3. Department of Commerce offers up to $1 million annually to aid tech entrepreneurs
4. Annual Bioethics Forum to explore genetic testing
5. Annual Conference Honors Tech Grant Winners
6. Venture Investors early-stage fund grows to $115 million
7. Investor warns of angel-venture funding gap
8. Brazilian bio-industry should impress American investors
9. Investors raise $25 million for biodiesel plant
10. Bio-energy and cleantech grab attention of investors
11. Venture Investors to open Michigan office

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue: ,, Carbondioxide Incubators - A Global M...com/p0164368/Carbondioxide-Incubators---A-Global-M...most critical equipment used in microbiology, gene... providing a controlled environment to grow and st...
(Date:12/2/2009)...swire/ -- The world,s first concept demonstration ...hrough alternative to replace a petrochemically pr...rubber with renewable biomass, made their debut in...on display at a lounge in the common departure are...ut December 21, while the other tire will make app...
(Date:12/2/2009)...cember 2 , - "Bolstering ...itage" , Coinciding with the Internationa... Republic is hosting an international conference i...biological resources in Africa. The,conference wil...isters,scientific experts, private companies, rep...
(Date:12/2/2009)...el, December 2 Gamida Cell announc...nical (animal study) safety and,efficacy of a gene...ill,Cornell Medical College and Gamida Cell. The p...as such as Cooley,s Anemia. , Gamida Cell... ex vivo,populations of stem/progenitor cells. Th...
Breaking Biology Technology:Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Libreville International Conference 2-3 June 2010 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3
...EHOVOT, Israel and JERSEY CITY, New Jersey, Decemb...,innovative molecular diagnostic company leveragin...lidated financial results for the quarter ended,Se...The company recorded revenues for the third quarte...d from the date of acquisition of Parkway Clinical...
...AN DIEGO, Dec. 4 Favrille, Inc.,(OTC Bulletin Boa...a health,information company focused on secure Web...ds (PHRs), announced today that two significant co...ive merger agreement have been met. , (Logo:...F521LOGO ) , "We are pleased to announce tha...
...ORT LAUDERDALE, Fla., Dec. 4 Imaging Diagnostic,S...r in laser optical breast,imaging, announced today...,adjunct to mammography is featured in the Decembe... http://www.newscom.com/cgi-bin/prnh/20040412/IM...ist at Charite Hospital in Berlin,Germany, authore...
Other Biology Technology:Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 2Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 3Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 4Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 5Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 6Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 7Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 8Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 9Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 10Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 2Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 3Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 4Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 5Imaging Diagnostic Systems CT Laser Mammography (CTLM) Technology Featured in Peer-Reviewed Journal 2
(Date:12/3/2009)...., Dec. 3 BIO-key Intern... in wireless public safety and finger-based biomet...ority of its shareholders at a Special Shareholder...ny,s Law Enforcement Division to Interact911 Mobil...t in favor and 1.2% were opposed. ,, (Logo: ht...
(Date:12/3/2009)...s or solar panels that repels grime and dirt? Expa...ric car? New Tel Aviv University research, just pu...kthrough in assembling peptides at the nano-scale ...e true in just a few years. , Operating in the r... meter) and even smaller, graduate student Lihi Ad...
(Date:12/3/2009)...Dec. 3, 2009) Van Andel Research Institute (VAR...lant hormone abscisic acid (ABA) works at the mole...l stresses such as drought and cold. Their findin...engineer crops that thrive in harsh environments a... The findings could also have implications for str...
Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3A window that washes itself? 2VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Insmed Provides Update on Supply of IPLEX 28TM 29 52763 1Insmed Provides Update on Supply of IPLEX 28TM 29 52763 2Insmed Provides Update on Supply of IPLEX 28TM 29 52763 3Questcor and Child Neurology Foundation Announce Creation of Infantile Spasms Awareness Week 52759 1Questcor and Child Neurology Foundation Announce Creation of Infantile Spasms Awareness Week 52759 2Questcor and Child Neurology Foundation Announce Creation of Infantile Spasms Awareness Week 52759 3Questcor and Child Neurology Foundation Announce Creation of Infantile Spasms Awareness Week 52759 4S C Medical Home Pilot for Diabetes Enrolls 1 110 4781 1S C Medical Home Pilot for Diabetes Enrolls 1 110 4781 2S C Medical Home Pilot for Diabetes Enrolls 1 110 4781 3
...tes and other nations commit to the path of biofue...r sustainable practices in an industry that will, ...Earth,s landscape in a significant way." , In a p...gazine, Melillo and 22 co-authors call for science...stry, which by 2050 could command as much land as ...
...ne for neuroblastoma and melanoma developed by s...edical Center in collaboration with investigators...t impact on tumor growth in mice, according to new...research journal Cancer Immunology, Immunotherapy...uce an immune system response, allowing for a pers...
...er ) show a highly selective behavior towards odor...at a single olfactory stimulus is often not suffic...urces or oviposition sites. Interestingly, the beh...er varieties, so-called "wildtypes". Natural odor...whereas artificial flavors induced a more differen...
Other Biology News:Thinking it through: Scientists call for policy to guide biofuels industry toward sustainability 2Thinking it through: Scientists call for policy to guide biofuels industry toward sustainability 3Children's National researchers develop novel anti-tumor vaccine 2What is wild? Odor attraction among different wildtype Drosophila 2What is wild? Odor attraction among different wildtype Drosophila 3
Bovine Albumin from Bovine Serum, BODIPY FL conjugated/tagged from Molecular Probes (Invitrogen)
Protein Expression Service (Insect cell) from Exon BioSystems
Bovine Albumin from Bovine Serum, Fluorescein conjugated/tagged from Molecular Probes (Invitrogen)
Goat Anti-Human PARAINFLUENZA VIRUS 2+3 Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: